Focus Stocks
Teva Lower With High Volume
Published on Wednesday, 21 December 2011 11:38 Written by TradersHuddle Staff
New York, December 21st (TradersHuddle.com) - Unusual high volume detected on shares of Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA), early in the trading session. Teva is currently trading lower by 2.27%, so definitely the sellers in control, as the stock's volume is on pace to break its average.
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) develops, manufactures and markets generic and branded human pharmaceuticals and active pharmaceutical ingredients. The Company produces antibiotics, oncological products, Alpha D3 for treatment of post-menopausal bone loss in women and Copaxone for treatment of multiple sclerosis.
Teva has already traded 0.78 times its 3-month average volume, and has calculated support and resistance at $36.88 and $43.12 respectively. Traders like to use volume as their lie detector for price action moves through predefined trading ranges.
The overall market index S&P 500 is trading lower by -0.7% from its previous trading close, which means that Teva stock is underperforming the overall market.
Related Articles
- Teva - Traders Waiting for Entry
- Will Teva recover?
- Teva’s Board of Directors Votes to Re-Elect Dr. Phillip Frost as Chairman of the Board
- Early Research Calls
- NASDAQ 100's Update, In focus: PCLN, NFLX, GILD, VRTX, TEVA
- Teva Issues Updated Conference Call Information for First Quarter 2012 Financial Results on May 9, 2012
- Teva Reports First Quarter 2012 Results
- Teva Appoints Michael Hayden as President of Global Research and Development and Chief Scientific Officer
- Teva settles Nuvigil litigation with Mylan
- Preliminary Data Suggest Spasticity May Be Reduced in Relapsing-Remitting Multiple Sclerosis Patients Who Transitioned to Teva’s COPAXONE®
Related Partner Headlines
- Teva's Board of Directors Votes to Re-Elect Dr. Phillip Frost as Chairman of the Board - Benzinga
- Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug Application for CEP-32496, A Novel BRAF(V600E) Inhibitor - Benzinga
- Teva Stock To Go Ex-dividend Tomorrow (TEVA) - TheStreet.com
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Drugs Loser - TheStreet.com
- UPDATE: Teva Posts Upbeat Q1 Profit, Declares Dividend - Benzinga
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Drugs Loser - TheStreet.com
- FDA Considering Letting Patients Purchase Drugs Without Prescriptions - Benzinga
- Teva Announces Preliminary Data Suggest Spasticity May Be Reduced in Relapsing-Remitting Multiple Sclerosis Patients Who Transitioned to Teva's COPAXONE - Benzinga
- TEVA: QNASLTM Phase III Data Indicate Investigational Therapy with New Mode of Delivery has Positive Safety and Effective Profile - Benzinga
- Teva Announces Launch of Generic Prometrium Capsules in the United States - Benzinga
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
Latest Partner Headlines
-
The Hoopla Point of No Return - TheStreet.com -
Dell, PetSmart: After-Hours Headlines - TheStreet.com -
China's Domestic Economy in Slowdown Mode - TheStreet.com -
Ford Hails Credit Upgrade as 'Once-in-a-Lifetime Event' - TheStreet.com -
The Easy Money Has Been Made - TheStreet.com -
F5 Networks Inc. (FFIV): Today's Featured Computer Software & Services Loser - TheStreet.com -
Lorillard Inc. (LO): Today's Featured Tobacco Loser - TheStreet.com -
Thermo Fisher Scientific Inc (TMO): Today's Featured Health Care Loser - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,502.81 Trade time:4:04PM EDT Value change:▼1.67 (-0.01%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,316.63 Trade time:4:32PM EDT Value change:▲0.64 (0.05%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.08 Trade time:5:16PM EDT Value change:▼8.13 (-0.29%)In The Wires
-
Duluth Metals Announces Normal Course Issuer Bid and Securities Repurchase Plan for its Class A Shares -
Howard Bancorp, Inc. Commences Previously Announced Rights Offering and Public Offering -
TriCo Bancshares Announces Quarterly Cash Dividend -
WestJet introduces new unaccompanied minor program -
Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting -
Shuffle Master, Inc. to Announce Second Quarter 2012 Results -
Businesses Say Sustainability is Vital to Long Term Growth, but Can Weaken Margins and Increase Short Term Costs, Accenture Study Finds -
Alere Inc. Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock









